Author:
Golabi Marjan,Kazemi Danial,Chadeganipour Amir Shayan,Fouladseresht Hamed,Sullman Mark J. M.,Ghezelbash Behrooz,Dastgerdi Ava Yeganegi,Eskandari Nahid
Publisher
Springer Science and Business Media LLC
Reference156 articles.
1. Gironi, M., C. Arnò, G. Comi, G. Penton-Rol, and R. Furlan. 2016. Multiple sclerosis and neurodegenerative diseases, 63–84. Immune rebalancing: Elsevier.
2. Golabi, M., F. Fathi, M. Samadi, M.S. Hesamian, and N. Eskandari. 2022. Identification of potential biomarkers in the peripheral blood mononuclear cells of relapsing-remitting multiple sclerosis patients. Inflammation 45 (4): 1815–1828.
3. Walton, C., R. King, L. Rechtman, W. Kaye, E. Leray, R.A. Marrie, et al. 2020. Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS. Multiple Sclerosis Journal 26 (14): 1816–1821.
4. Ghasemi, N., S. Razavi, and E. Nikzad. 2017. Multiple sclerosis: pathogenesis, symptoms, diagnoses and cell-based therapy. Cell Journal 19 (1): 1–10.
5. Chataway, J., A. Mander, N. Robertson, S. Sawcer, J. Deans, M. Fraser, et al. 2001. Multiple sclerosis in sibling pairs: An analysis of 250 families. Journal of Neurology, Neurosurgery, and Psychiatry 71 (6): 757.